Revvity's (RVTY) strong product portfolio raises optimism about the stock.

PacBio's (PACB) strong product demand and continued focus on R&D raise optimism about the stock.

PacBio's (PACB) strong product demand and continued focus on R&D raise optimism about the stock.

Axon Enterprise (AXON) gains from strength across its businesses, product introductions and complementary acquisitions. Rising costs and expenses may...

Axon Enterprise (AXON) gains from strength across its businesses, product introductions and complementary acquisitions. Rising costs and expenses may...

Trane Technologies (TT) gains from transformation initiatives, growth in the HVAC deals, and strength across bookings.

Glaukos (GKOS) continues to benefit from a robust product portfolio and favorable clinical trial results.

West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.

Progressive (PGR) is poised to grow from its compelling portfolio, leadership position, strength in Vehicle and Property businesses, healthy policies...

Cencora (COR) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.